SARS-CoV-2 weakens immune-cell response to vaccine

SARS-CoV-2 weakens immune-cell response to vaccine

Scanning electron micrograph of a cell (purple) infected with the Omicron strain of SARS-CoV-2 virus particles (orange), isolated from a patient sample and colorized. CREDIT: NIAID/NIH The magnitude and quality of a key immune cell’s response to vaccination with two...
FDA advisers recommend Pfizer RSV vax for 60+

FDA advisers recommend Pfizer RSV vax for 60+

The Food and Drug Administration (FDA) vaccine advisory group recommended approval of Pfizer’s respiratory syncytial virus (RSV) vaccine for use in people 60 and older, ahead of similar deliberations for GSK’s RSV vaccine in the same age-group. The recommendation came...
HIV vax aims to block virus before it takes root

HIV vax aims to block virus before it takes root

The vaccine is designed to specifically enter basal, or base, cells in the mucosal epithelium. As those basal cells differentiate to build up the epithelial tissue, the vaccine is passed on to all newly made cells (represented in green). CREDIT: Marie-Claire Gauduin,...
Vaccine targets life-threatening fungal infections

Vaccine targets life-threatening fungal infections

A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases. Fungal infections cause more than 1.5 million deaths worldwide...
New vaccine platform may make virus-fighting easier

New vaccine platform may make virus-fighting easier

3D print of HIV surface protein gp120. An antibody also is attached at the top (green and blue). When antibodies stick to viruses, they may prevent or limit infection of host cells. CREDIT: NIH To many, EV stands for “electric vehicle.” To researchers at Harvard...